Table 2.
Study cohort characteristics.
| Characteristics | Cohort 1—overall cohort (n = 3015; 100%) | Cohort 2 (n = 1332; 44.2%) |
|---|---|---|
| Age | ||
| Median (IQR) | 63 (52–72) | 60 (50–70) |
| Mean (SD) | 61.6 (13.26) | 59.5 (13.3) |
| Min—Max | 19–95 | 19–95 |
| ≥65 years, n (%) | 1361 (45.1) | 519 (39.0) |
| Sex, n (%) | ||
| Female | 1977 (65.6) | 907 (68.1) |
| Male | 1038 (34.4) | 425 (31.9) |
| Tumor type, n (%) | ||
| Breast | 1155 (38.3) | 564 (42.3) |
| Gastrointestinal | 696 (23.1) | 305 (22.9) |
| Genitourinary | 254 (8.4) | 105 (7.9) |
| Thoracic oncology | 116 (3.8) | 74 (5.6) |
| Gynecologic | 175 (5.8) | 70 (5.3) |
| Others | 433 (14.4) | 126 (9.4) |
| Stage, n (%) | ||
| Non-metastatic | 1087 (35.1) | 591 (44.4) |
| Metastatic | 567 (18.8) | 294 (22.1) |
| Missing | 1661 (55.1) | 447 (33.5) |
| Cancer center type, n (%) | ||
| Hospital center | 748 (24.8%) | 101 (7.6%) |
| Academic hospital | 163 (5.4) | 73 (5.5%) |
| Comprehensive cancer center | 1066 (35.4%) | 648 (48.6%) |
| Private hospital | 987 (32.7%) | 476 (35.7%) |
| Private nonprofit hospital | 51 (1.7%) | 34 (2.6%) |